SI
AMGN icon

Sofinnova Investments’s Amgen AMGN Stock Holding History

Sofinnova Investments’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-168,500
Closed -$39.7M – 71
2020
Q2 		$39.7M Buy
+168,500
New +$38.4M 2.51% 7
2019
Q3 		– Sell
-50,000
Closed -$9.21M – 76
2019
Q2 		$9.21M Buy
+50,000
New +$8.95M 0.85% 30

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sofinnova Investments's AMGN Position: Q3 2021 in Review

Sofinnova Investments sold out of Amgen (AMGN) in Q3 2021, closing a stake of 40,500 shares — an estimated $9.87M sold.

Sofinnova Investments first reported a position in AMGN in Q3 2019 and held it in 5 quarters. The position peaked at $37.9M in Q4 2020. 2,131 funds tracked by Wall St. Rank hold AMGN as of Q3 2021.

  • Sofinnova Investments reported no remaining Amgen position as of Q3 2021 after selling out during the quarter.
  • Sofinnova Investments sold 40,500 Amgen shares in Q3 2021, an estimated $9.87M.
  • Sofinnova Investments first reported a position in Amgen in Q3 2019 and held it in 5 quarters.
  • Sofinnova Investments's Amgen position peaked at $37.9M in Q4 2020.
  • 2,131 funds tracked by Wall St. Rank held Amgen as of Q3 2021.

Based on Sofinnova Investments's 13F filing for Q3 2021, filed 15 Nov 2021.